Buscar resultados de ensayos clínicos
Leiomyosarcoma - 28 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble - Condición: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas Fecha: 2014-05-05 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma Condición: Advanced or Metastatic Liposarcoma or Leiomyosarcoma Fecha: 2012-08-06 Intervenciones:
|
Completed |
Nombre del estudio: Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma Condición:
Fecha: 2006-01-24 Intervenciones: Drug: gemcitabine, docetaxel, doxorubicin Cycles = 28 days |
Active, not recruiting |
Nombre del estudio: Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma Condición:
Fecha: 2006-12-19 Intervenciones: Drug: Letrozole 2.5 mg Tablet By Mouth Daily for 12 Weeks. |
Completed |
Nombre del estudio: Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Condición:
Fecha: 2006-09-19 Intervenciones: Drug: sunitinib malate Given orally Other Names: |
Completed |
Nombre del estudio: Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Condición:
|
Active, not recruiting |
Nombre del estudio: Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy Condición:
|
Recruiting |
Nombre del estudio: Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Condición:
Intervenciones:
|
Completed |
Nombre del estudio: Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus Condición:
Fecha: 2008-01-31 Intervenciones: Drug: Docetaxel plus Gemcitabine Gemcitabine 900 mg/m2 IV over 90 minutes day 1 Gemcitabine 900 mg/m2 IV |
Not yet recruiting |
Nombre del estudio: Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery Condición:
Fecha: 2017-03-01 Intervenciones:
|